Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$93.6 - $388.02 $9,453 - $39,190
-101 Closed
0 $0
Q4 2023

Feb 14, 2024

BUY
$306.88 - $380.0 $9,820 - $12,160
32 Added 30.19%
138 $52.2 Million
Q3 2023

Nov 13, 2023

BUY
$315.92 - $397.36 $1,579 - $1,986
5 Added 4.95%
106 $33.7 Million
Q2 2023

May 13, 2024

SELL
$346.15 - $392.09 $23,538 - $26,662
-68 Reduced 40.24%
101 $38.7 Million
Q2 2023

Sep 12, 2023

SELL
$346.15 - $392.09 $23,538 - $26,662
-68 Reduced 40.24%
101 $38.7 Million
Q1 2023

May 13, 2024

BUY
$323.56 - $373.36 $10,030 - $11,574
31 Added 22.46%
169 $63.1 Million
Q1 2023

Sep 12, 2023

BUY
$323.56 - $373.36 $27,826 - $32,108
86 Added 103.61%
169 $63.1 Million
Q4 2022

Sep 11, 2023

BUY
$248.67 - $334.17 $20,639 - $27,736
83 New
83 $27.4 Million

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.65B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.